Back

Serum amyloid A as a predictor of coronary fatty plaque progression: a comparative analysis of cardiometabolic biomarkers

30 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Artificial intelligence and cardiovascular disease (2) Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Sahil Ghay

Mount Sinai Medical Centre Miami Beach, Aventura (United States of America)

7 More presentations in this session

Presentation thumbnail
HDLox and neuronal injury biomarkers as early signals of silent strokes after high thromboembolic risk transcatheter procedures
Associate Professor S. Tzikas (Thessaloniki, GR)
Abstract
Presentation thumbnail
An inflammatory–hyperglycemic stress index predicts mortality in acute coronary syndrome: development and external validation in two large cohorts
Miss K. Zhang (Beijing, CN)
Abstract
Presentation thumbnail
Simple ultrasound parameters-carotid plaque and coronary Doppler velocity at rest- predict cardiovascular events better than clinical risk factors: the PENSIAMOCI-PRIMA screening study.
Doctor F. Rigo (Dolo, IT)
Abstract
Presentation thumbnail
Inflammatory resilience index combining hsCRP, albumin, and appendicular lean mass predicts functional limitations and mortality in U.S. adults: derivation and external validation study.
Doctor V. Jaiswal (Glenview, US)
Abstract
Presentation thumbnail
Joint association of stress hyperglycemia ratio and inflammatory-metabolic-coagulation profiles with long-term adverse outcomes in premature myocardial infarction
Professor J. Gao (Tianjin, CN)
Abstract

Access the full session

Session thumbnail
Artificial intelligence and cardiovascular disease (2)

The Event

Event poster

ESC Congress 2026

30 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
The natural history and prediction of 10-year plaque progression on serial coronary CT angiography
26 August 2023
thumbnail
Congress Presentation
Serum amyloid a1 reflects activation of interleukin 1b, 6, and 17 and is specifically upregulated in heart failure with a preserved ejection fraction
20 May 2025
thumbnail
Congress Presentation
Change in remnant lipid-inflammatory index predicts long-term outcomes in AMI survivors with achieved LDL-C targets
21 March 2026
thumbnail
Congress Presentation
Plasma levels of amyloid beta 1-40 are associated with the rate of progression of carotid subclinical atherosclerosis in postmenopausal women
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources